Stock Analysts

What to Expect From Thomson Reuters (TRI) in Q4 Earnings?

Thomson Reuters Corporation TRI is slated to report fourth-quarter 2017 results before the market opens on Feb 8. In the previous quarter, the company’s earnings surpassed the Zacks Consensus Estimate by 10 cents. Notably, the company topped the Zacks Consensus Estimate in each of the trailing four quarters with a positive earnings surprise of 14.3%. […]

Stock Analysts

Colfax (CFX) Q4 Earnings Beat, Fall Y/Y, ’18 View Intact

Machinery company Colfax Corporation CFX pulled off a positive earnings surprise in the fourth quarter of 2017 with adjusted earnings per share of 45 cents surpassing the Zacks Consensus Estimate of 44 cents by roughly 2.3%. However, the adjusted bottom line fell 13.5% from the year-ago tally of 52 cents. Despite gains from lower taxes, profitability suffered from a decline in adjusted operating income and higher interest expenses. […]

Technicals

Ford Motor (F) in Focus: Stock Moves 5.1% Higher

Ford Motor Company F was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the continued downtrend in the company, as the stock is down 18.5% in the past one month time frame […]

Technicals

Should You Buy Teradata (TDC) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and Teradata Corporation TDC may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Teradata is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. […]

Technicals

Keryx (KERX) Posts Wider Q4 Loss, Sales Beat, Shares Down

Keryx Biopharmaceuticals Inc. KERX ) is a Boston-based biopharmaceutical company working in the field of renal diseases. The company’s only product is Auryxia (ferric citrate) which is marketed in the United States since 2014 for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis […]

Technicals

Broadcom (AVGO) Looks Good: Stock Adds 5.4% in Session

Broadcom Limited AVGO was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 11.7% in the past one-month time frame. […]